Longitudinal MR Imaging of Iron in Multiple Sclerosis: An Imaging Marker of Disease

Published Online:https://doi.org/10.1148/radiol.13130474

R2* mapping has a strong correlation to disease and a high intrasubject reliability; therefore, this method could be useful as a surrogate marker to follow disease disability during short intervals in individuals or populations with multiple sclerosis.

Purpose

To investigate the relationship between magnetic resonance (MR) imaging markers of iron content and disease severity in patients with multiple sclerosis (MS) over a 2-year period.

Materials and Methods

This prospective study was approved by the local ethics committee, and written informed consent was obtained from all participants. Seventeen patients with MS and 17 control subjects were examined twice, 2 years apart, by using phase imaging and transverse relaxation (R2*) mapping at 4.7 T. Quantitative differences in iron content in deep gray matter between patients and control subjects were evaluated with repeated-measures multivariate analysis of variance separately for R2* mapping and phase imaging. Multiple regression analysis was used to evaluate correlations of MR imaging measures, both 2-year–difference and single-time measurements, to baseline disease severity.

Results

R2* mapping using 2-year–difference measurements had the highest correlation to disease severity (r = 0.905, P < .001) compared with R2* mapping using single-time measurements (r = 0.560, P = .019) and phase imaging by using either single-time (r = 0.539, P = .026) or 2-year–difference (r = 0.644, P = .005) measurements. Significant increases in R2* occur during 2 years in the substantia nigra (P < .001) and globus pallidus (P = .035), which are both predictors of disease in regression analysis, in patients compared with control subjects. There were group differences in the substantia nigra, globus pallidus, pulvinar thalamus, thalamus, and caudate nucleus, compared with control subjects with R2* mapping (P < .05), and group differences in the caudate nucleus and pulvinar thalamus, compared with control subjects with phase imaging (P < .05).

Conclusion

There are significant changes in deep gray matter iron content in MS during 2 years measured with MR imaging, changes that are strongly related to physical disability. Longitudinal measurements may produce a higher correlation to disease severity compared with single-time measurements because baseline iron content of deep gray matter is variable among subjects.

©RSNA, 2013

References

  • 1. Williams R, Buchheit CL, Berman NE, LeVine SM. Pathogenic implications of iron accumulation in multiple sclerosis. J Neurochem 2012;120(1):7–25. Crossref, MedlineGoogle Scholar
  • 2. Bagnato F, Hametner S, Yao B, et al. Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain 2011;134(pt 12):3602–3615. Crossref, MedlineGoogle Scholar
  • 3. Khalil M, Langkammer C, Ropele S, et al. Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology 2011;77(18):1691–1697. Crossref, MedlineGoogle Scholar
  • 4. Lebel RM, Eissa A, Seres P, Blevins G, Wilman AH. Quantitative high-field imaging of sub-cortical gray matter in multiple sclerosis. Mult Scler 2012;18(4):433–441. Crossref, MedlineGoogle Scholar
  • 5. Zhang Y, Zabad RK, Wei X, Metz LM, Hill MD, Mitchell JR. Deep grey matter “black T2” on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis. Mult Scler 2007;13(7):880–883. Crossref, MedlineGoogle Scholar
  • 6. Benarroch EE. Brain iron homeostasis and neurodegenerative disease. Neurology 2009;72(16):1436–1440. Crossref, MedlineGoogle Scholar
  • 7. Hallgren B, Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958;3(1):41–51. Crossref, MedlineGoogle Scholar
  • 8. Drayer B, Burger P, Hurwitz B, Dawson D, Cain J. Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? AJR Am J Roentgenol 1987;149(2):357–363. Crossref, MedlineGoogle Scholar
  • 9. Meguro R, Asano Y, Odagiri S, Li C, Shoumura K. Cellular and subcellular localizations of nonheme ferric and ferrous iron in the rat brain: a light and electron microscopic study by the perfusion-Perls and -Turnbull methods. Arch Histol Cytol 2008;71(4):205–222. Crossref, MedlineGoogle Scholar
  • 10. Miki Y, Grossman RI, Udupa JK, et al. Relapsing-remitting multiple sclerosis: longitudinal analysis of MR images—lack of correlation between changes in T2 lesion volume and clinical findings. Radiology 1999;213(2):395–399. LinkGoogle Scholar
  • 11. Kappos L, Moeri D, Radue EW, et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group. Lancet 1999; 353:964–969. Crossref, MedlineGoogle Scholar
  • 12. Brex PA, Ciccarelli O, O’Riordan JI, Sailer M, Thompson AJ, Miller DH. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002;346(3):158–164. Crossref, MedlineGoogle Scholar
  • 13. Rudick RA, Lee JC, Simon J, Fisher E. Significance of T2 lesions in multiple sclerosis: a 13-year longitudinal study. Ann Neurol 2006;60(2):236–242. Crossref, MedlineGoogle Scholar
  • 14. Gelman N, Gorell JM, Barker PB, et al. MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 1999;210(3):759–767. LinkGoogle Scholar
  • 15. Haacke EM, Cheng NY, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005 23(1):1–25. Google Scholar
  • 16. Ogg RJ, Langston JW, Haacke EM, Steen RG, Taylor JS. The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn Reson Imaging 1999;17(8):1141–1148. Crossref, MedlineGoogle Scholar
  • 17. Hammond KE, Metcalf M, Carvajal L, et al. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol 2008;64(6):707–713. Crossref, MedlineGoogle Scholar
  • 18. Brass SD, Benedict RHB, Weinstock-Guttman B, Munschauer F, Bakshi R. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler 2006;12(4):437–444. Crossref, MedlineGoogle Scholar
  • 19. Neema M, Arora A, Healy BC, et al. Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis. J Neuroimaging 2009;19(1):3–8. Crossref, MedlineGoogle Scholar
  • 20. Zhang Y, Metz LM, Yong VW, Mitchell JR. 3T deep gray matter T2 hypointensity correlates with disability over time in stable relapsing-remitting multiple sclerosis: a 3-year pilot study. J Neurol Sci 2010;297(1–2):76–81. Crossref, MedlineGoogle Scholar
  • 21. Bermel RA, Puli SR, Rudick RA, et al. Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. Arch Neurol 2005;62(9):1371–1376. Crossref, MedlineGoogle Scholar
  • 22. Langkammer C, Krebs N, Goessler W, et al. Quantitative MR imaging of brain iron: a postmortem validation study. Radiology 2010;257(2):455–462. LinkGoogle Scholar
  • 23. Walsh AJ, Lebel RM, Eissa A, et al. Multiple sclerosis: validation of MR imaging for quantification and detection of iron. Radiology 2013;267(2):531–542. LinkGoogle Scholar
  • 24. Peters AM, Brookes MJ, Hoogenraad FG, et al. T2* measurements in human brain at 1.5, 3 and 7 T. Magn Reson Imaging 2007;25(6):748–753. Crossref, MedlineGoogle Scholar
  • 25. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.” Ann Neurol 2005;58(6):840–846. Google Scholar
  • 26. Du YPP, Jin ZY, Hu YZ, Tanabe J. Multi-echo acquisition of MR angiography and venography of the brain at 3 Tesla. J Magn Reson Imaging 2009;30(2):449–454. Crossref, MedlineGoogle Scholar
  • 27. Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52(3):612–618. Crossref, MedlineGoogle Scholar
  • 28. Walsh AJ, Eissa A, Blevins G, Wilman AH. Susceptibility phase imaging with improved image contrast using moving window phase gradient fitting and minimal filtering. J Magn Reson Imaging 2012;36(6):1460–1469. Crossref, MedlineGoogle Scholar
  • 29. Rasband WS. ImageJ. Bethesda, Md: U.S. National Institutes of Health, 1997–2011. Google Scholar
  • 30. Roxburgh RH, Seaman SR, Masterman T, et al. Multiple sclerosis severity score: using disability and disease duration to rate disease severity. Neurology 2005;64(7):1144–1151. Crossref, MedlineGoogle Scholar
  • 31. Cheah JH, Kim SF, Hester LD, et al. NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron 2006;51(4):431–440. Crossref, MedlineGoogle Scholar
  • 32. Walsh AJ, Wilman AH. Susceptibility phase imaging with comparison to R2 mapping of iron-rich deep grey matter. Neuroimage 2011;57(2):452–461. Crossref, MedlineGoogle Scholar
  • 33. Schäfer A, Wharton S, Gowland P, Bowtell R. Using magnetic field simulation to study susceptibility-related phase contrast in gradient echo MRI. Neuroimage 2009;48(1):126–137. Crossref, MedlineGoogle Scholar
  • 34. Du YP, Chu R, Hwang D, et al. Fast multislice mapping of the myelin water fraction using multicompartment analysis of T2* decay at 3T: a preliminary postmortem study. Magn Reson Med 2007;58(5):865–870. Crossref, MedlineGoogle Scholar
  • 35. Yablonskiy DA, Haacke EM. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 1994;32(6):749–763. Crossref, MedlineGoogle Scholar
  • 36. Sati P, van Gelderen P, Silva AC, et al. Micro-compartment specific T2* relaxation in the brain. Neuroimage 2013;77:268–278. Crossref, MedlineGoogle Scholar
  • 37. Dalton CM, Chard DT, Davies GR, et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004;127(Pt 5):1101–1107. Crossref, MedlineGoogle Scholar
  • 38. Bendfeldt K, Hofstetter L, Kuster P, et al. Longitudinal gray matter changes in multiple sclerosis—differential scanner and overall disease-related effects. Hum Brain Mapp 2012;33(5):1225–1245. Crossref, MedlineGoogle Scholar
  • 39. Rooney WD, Johnson G, Li X, et al. Magnetic field and tissue dependencies of human brain longitudinal 1H2O relaxation in vivo. Magn Reson Med 2007;57(2):308–318. Crossref, MedlineGoogle Scholar

Article History

Received February 22, 2013; revision requested April 15; final revision received May 1; accepted May 16; final version accepted May 29.
Published online: Jan 2014
Published in print: Jan 2014